Article Contents ::
- 1 Details About Generic Salt :: Flucytos
- 2 Main Medicine Class:: Anti-infective,Antifungal
- 3 (flew-SITE-oh-seen) Ancobon Class: Anti-infective/Antifungal
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Flucytos
Main Medicine Class:: Anti-infective,Antifungal
(flew-SITE-oh-seen)
Ancobon
Class: Anti-infective/Antifungal
Drugs Class ::
Action Exact mechanism is unknown; interferes with DNA and RNA synthesis. Active against Candida and Cryptococcus.
Indications for Drugs ::
Indications Treatment of serious infections caused by susceptible strains of Candida or Cryptococcus. unlabeled use(s): Treatment of Chromomycosis.
Drug Dose ::
Route/Dosage
ADULTS & CHILDREN > 50 kg: PO 50 to 150 mg/kg/day in divided doses q 6 hr.
Contraindication ::
Contraindications Standard considerations.
Drug Precautions ::
Precautions
Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy not established. Bone marrow depression: Use with extreme caution in patients with bone marrow depression or those at risk (eg, hematologic disease, radiation treatment, other bone marrow suppressant drugs). Hepatic or renal impairment: Use with extreme caution in patients with renal impairment. Adjust dose according to blood levels and monitor hepatic function.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CV: Cardiac arrest. CNS: Ataxia; hearing loss; headache; sedation; confusion; fatigue; weakness; dizziness; vertigo, paresthesia; parkinsonism; peripheral neuropathy; pyrexia; hallucinations; psychosis. DERM: Rash; pruritus; urticaria; photosensitivity. GI: Nausea; emesis; abdominal pain; diarrhea; anorexia; duodenal ulcer; GI hemorrhage. GU: Azotemia; creatinine and BUN elevation; crystalluria; renal failure; dry mouth. HEMA: Anemia; agranulocytosis; aplastic anemia; eosinophilia; leukopenia; pancytopenia; thrombocytopenia. HEPA: Hepatic dysfunction; jaundice; ulcerative colitis; increased bilirubin; elevated hepatic enzymes. META: Hypoglycemia; hypokalemia. RESP: Respiratory arrest; chest pain; dyspnea.
Drug Mode of Action ::
Action Exact mechanism is unknown; interferes with DNA and RNA synthesis. Active against Candida and Cryptococcus.
Drug Interactions ::
Interactions
Amphotericin B: Increased therapeutic action and toxicity of flucytosine. Cytosine: Inactivates antifungal activity of flucytosine.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies.
- Ensure that baseline liver function tests, BUN, and creatinine, electrolytes, and glucose have been obtained before beginning therapy, and monitor at regular intervals.
- Obtain baseline CBC with differential and repeat daily. Assess for bone marrow depression.
- Obtain specimens for culture and sensitivity before beginning therapy.
- Monitor BP at regular intervals during therapy. Assess for cardiovascular collapse.
- Monitor blood levels of drug closely in patient with impaired renal function.
- If patient has ataxia, hearing loss, headache, paresthesia, peripheral neuropathy, pyrexia, hallucinations, psychosis, laboratory evidence of liver or renal dysfunction, chest pain, or respiratory distress, notify physician immediately.
|
Drug Storage/Management ::
Administration/Storage
- Administer capsules a few at a time over 15 min to minimize GI upset.
Drug Notes ::
Patient/Family Education
- Instruct patient to take capsules a few at a time over a 15-min period with food.
- Instruct diabetic patients to monitor glucose closely.
- Instruct patient to report the following symptoms to physician: Sore throat, cough, unusual bleeding or bruising, petechiae, blood in urine, bleeding gums, abdominal pain, nausea, vomiting, change in color or consistency of stools, fever, yellow skin/eyes, ataxia, hearing loss, paresthesia, shaking, tingling, altered sensation, parkinsonism, peripheral neuropathy, hallucinations or psychosis, anorexia, increased fatigue, rash or itching.
- Warn patient to seek emergency care if respiratory distress or chest pain occur.
- Advise patient that drug may cause dizziness or vertigo and to use caution while driving or performing other tasks requiring mental alertness.
- Caution patient to avoid unnecessary exposure to sunlight and to use sunscreen and wear protective clothing to avoid photosensitivity reaction.